Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial AP Porsteinsson, LT Drye, BG Pollock, DP Devanand, C Frangakis, ... Jama 311 (7), 682-691, 2014 | 384 | 2014 |
Sertraline for the treatment of depression in Alzheimer disease PB Rosenberg, BK Martin, C Frangakis, JE Mintzer, D Weintraub, ... The American Journal of Geriatric Psychiatry 18 (2), 136-145, 2010 | 215 | 2010 |
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes D Weintraub, PB Rosenberg, BK Martin, C Frangakis, JE Mintzer, ... The American Journal of Geriatric Psychiatry 18 (4), 332-340, 2010 | 157 | 2010 |
Safety and efficacy of methylphenidate for apathy in Alzheimer’s disease: a randomized, placebo-controlled trial PB Rosenberg, KL Lanctôt, LT Drye, N Herrmann, RW Scherer, ... The Journal of clinical psychiatry 74 (8), 810-816, 2013 | 142 | 2013 |
Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial C Fields, L Drye, V Vaidya, C Lyketsos, ADAPT Research Group The American Journal of Geriatric Psychiatry 20 (6), 505-513, 2012 | 70 | 2012 |
Outcome of treatment of uveitic macular edema: the multicenter uveitis steroid treatment trial 2-year results O Tomkins-Netzer, S Lightman, L Drye, J Kempen, GN Holland, NA Rao, ... Ophthalmology 122 (11), 2351-2359, 2015 | 67 | 2015 |
Citalopram for agitation in Alzheimer’s disease: design and methods LT Drye, Z Ismail, AP Porsteinsson, PB Rosenberg, D Weintraub, ... Alzheimer's & Dementia 8 (2), 121-130, 2012 | 58 | 2012 |
Benefits of systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, and panuveitis: fifty-four–month … Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group Ophthalmology 122 (10), 1967-1975, 2015 | 57 | 2015 |
Associations among visual acuity and vision-and health-related quality of life among patients in the multicenter uveitis steroid treatment trial KD Frick, LT Drye, JH Kempen, JP Dunn, GN Holland, P Latkany, NA Rao, ... Investigative ophthalmology & visual science 53 (3), 1169-1176, 2012 | 56 | 2012 |
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial LT Drye, D Spragg, DP Devanand, C Frangakis, C Marano, CL Meinert, ... PloS one 9 (6), e98426, 2014 | 52 | 2014 |
Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group Alzheimer's & Dementia 9 (6), 714-723, 2013 | 52 | 2013 |
Effects of citalopram on neuropsychiatric symptoms in Alzheimer’s dementia: evidence from the CitAD study AK Leonpacher, ME Peters, LT Drye, KM Makino, JA Newell, ... American Journal of Psychiatry 173 (5), 473-480, 2016 | 47 | 2016 |
Heterogeneity of treatment response to citalopram for patients with Alzheimer’s disease with aggression or agitation: the CitAD randomized clinical trial LS Schneider, C Frangakis, LT Drye, DP Devanand, CM Marano, ... American Journal of Psychiatry 173 (5), 465-472, 2016 | 43 | 2016 |
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease ML Hacker, J Tonascia, M Turchan, A Currie, L Heusinkveld, PE Konrad, ... Parkinsonism & related disorders 21 (10), 1177-1183, 2015 | 43 | 2015 |
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease CA Munro, CF Longmire, LT Drye, BK Martin, CE Frangakis, CL Meinert, ... The American Journal of Geriatric Psychiatry 20 (12), 1036-1044, 2012 | 41 | 2012 |
Hypotony in patients with uveitis: the Multicenter Uveitis Steroid Treatment (MUST) trial HN Sen, LT Drye, DA Goldstein, TA Larson, PT Merrill, PR Pavan, ... Ocular immunology and inflammation 20 (2), 104-112, 2012 | 36 | 2012 |
Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo controlled trial KL Lanctôt, SA Chau, N Herrmann, LT Drye, PB Rosenberg, RW Scherer, ... International psychogeriatrics/IPA 26 (2), 239, 2014 | 34 | 2014 |
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis EA Sugar, JT Holbrook, JH Kempen, AE Burke, LT Drye, JE Thorne, ... Ophthalmology 121 (10), 1855-1862, 2014 | 30 | 2014 |
Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease ML Hacker, MR DeLong, M Turchan, LE Heusinkveld, JL Ostrem, ... Neurology 91 (5), e463-e471, 2018 | 29 | 2018 |
Incidence and long-term outcomes of the human immunodefıciency virus neuroretinal disorder in patients with AIDS DA Jabs, L Drye, ML Van Natta, JE Thorne, GN Holland, ... Ophthalmology 122 (4), 760-768, 2015 | 27 | 2015 |